102 related articles for article (PubMed ID: 16621929)
21. CT color mapping of the arterial enhancement fraction of VX2 carcinoma implanted in rabbit liver: comparison with perfusion CT.
Kim KW; Lee JM; Kim JH; Klotz E; Kim HC; Han JK; Choi BI
AJR Am J Roentgenol; 2011 Jan; 196(1):102-8. PubMed ID: 21178053
[TBL] [Abstract][Full Text] [Related]
22. Hepatic perfusion in a tumor model using DCE-CT: an accuracy and precision study.
Stewart EE; Chen X; Hadway J; Lee TY
Phys Med Biol; 2008 Aug; 53(16):4249-67. PubMed ID: 18653923
[TBL] [Abstract][Full Text] [Related]
23. Establishing models of portal vein occlusion and evaluating value of multi-slice CT in hepatic VX2 tumor in rabbits.
Qi YY; Zou LG; Liang P; Zhang D
World J Gastroenterol; 2007 Jun; 13(24):3333-41. PubMed ID: 17659672
[TBL] [Abstract][Full Text] [Related]
24. Quantification of [(18)F]FDG uptake in the normal liver using dynamic PET: impact and modeling of the dual hepatic blood supply.
Brix G; Ziegler SI; Bellemann ME; Doll J; Schosser R; Lucht R; Krieter H; Nosske D; Haberkorn U
J Nucl Med; 2001 Aug; 42(8):1265-73. PubMed ID: 11483690
[TBL] [Abstract][Full Text] [Related]
25. A quantitative method for estimating hepatic blood flow using a dual-input single-compartment model.
Miyazaki S; Murase K; Yoshikawa T; Morimoto S; Ohno Y; Sugimura K
Br J Radiol; 2008 Oct; 81(970):790-800. PubMed ID: 18591199
[TBL] [Abstract][Full Text] [Related]
26. 1999 ARRS Executive Council Award. Contrast-enhanced CT of small hypovascular hepatic tumors: effect of lesion enhancement on conspicuity in rabbits. American Roentgen Ray Society.
Kuszyk BS; Bluemke DA; Choti MA; Horton KM; Magee CA; Fishman EK
AJR Am J Roentgenol; 2000 Feb; 174(2):471-5. PubMed ID: 10658727
[TBL] [Abstract][Full Text] [Related]
27. Comparison of dynamic FDG-microPET study in a rabbit turpentine-induced inflammatory model and in a rabbit VX2 tumor model.
Hamazawa Y; Koyama K; Okamura T; Wada Y; Wakasa T; Okuma T; Watanabe Y; Inoue Y
Ann Nucl Med; 2007 Jan; 21(1):47-55. PubMed ID: 17373336
[TBL] [Abstract][Full Text] [Related]
28. Experimental study on angiogenesis in a rabbit VX2 early liver tumour by perfusion computed tomography.
Jiang HJ; Lu HB; Zhang ZR; Wang YM; Huang Q; Huang YH; Li JP; Shu SJ; Wang JE
J Int Med Res; 2010; 38(3):929-39. PubMed ID: 20819429
[TBL] [Abstract][Full Text] [Related]
29. Increased hepatic blood flow during enteral immune-enhancing diet gavage requires intact enterohepatic bile cycling.
Nagengast AK; Hurt RT; Downard CD; Smith JW; Garrison RN; Matheson PJ
Nutrition; 2014 Mar; 30(3):313-8. PubMed ID: 24355437
[TBL] [Abstract][Full Text] [Related]
30. Bioevaluation study of 32P-CP-PLLA particle brachytherapy in a rabbit VX2 lung tumor model.
Xu Yp; Yang M; Pan Dh; Wang Lz; Liu L; Huang P; Shao G
Appl Radiat Isot; 2012 Apr; 70(4):583-8. PubMed ID: 22245365
[TBL] [Abstract][Full Text] [Related]
31. Multiparametric monitoring of early response to antiangiogenic therapy: a sequential perfusion CT and PET/CT study in a rabbit VX2 tumor model.
Kim JI; Lee HJ; Kim YJ; Kim KG; Lee KW; Lee JH; Lee HJ; Lee WW
ScientificWorldJournal; 2014; 2014():701954. PubMed ID: 25383376
[TBL] [Abstract][Full Text] [Related]
32. Non-invasive estimation of hepatic glucose uptake from [18F]FDG PET images using tissue-derived input functions.
Kudomi N; Järvisalo MJ; Kiss J; Borra R; Viljanen A; Viljanen T; Savunen T; Knuuti J; Iida H; Nuutila P; Iozzo P
Eur J Nucl Med Mol Imaging; 2009 Dec; 36(12):2014-26. PubMed ID: 19526238
[TBL] [Abstract][Full Text] [Related]
33. Radiofrequency ablation: Effect of pharmacologic modulation of hepatic and renal blood flow on coagulation diameter in a VX2 tumor model.
Horkan C; Ahmed M; Liu Z; Gazelle GS; Solazzo SA; Kruskal JB; Goldberg SN
J Vasc Interv Radiol; 2004 Mar; 15(3):269-74. PubMed ID: 15028812
[TBL] [Abstract][Full Text] [Related]
34. CT assessment of liver hemodynamics in patients with hepatocellular carcinoma after argon-helium cryoablation.
Hao XJ; Li JP; Jiang HJ; Li DQ; Ling ZS; Xue LM; Feng GL
Hepatobiliary Pancreat Dis Int; 2013 Dec; 12(6):617-21. PubMed ID: 24322747
[TBL] [Abstract][Full Text] [Related]
35. Comparison of hepatic VX2-carcinomas after intra-arterial, intraportal and intraparenchymal tumor cell injection. An angiographic and computed tomographic study in the rabbit.
Burgener FA; Violante MR
Invest Radiol; 1979; 14(5):410-4. PubMed ID: 500305
[TBL] [Abstract][Full Text] [Related]
36. In search of biologic correlates for liver texture on portal-phase CT.
Ganeshan B; Miles KA; Young RC; Chatwin CR
Acad Radiol; 2007 Sep; 14(9):1058-68. PubMed ID: 17707313
[TBL] [Abstract][Full Text] [Related]
37. Effect of an angiogenesis inhibitor on hepatic tumor perfusion and the implications for adjuvant cytotoxic therapy.
Stewart EE; Sun H; Chen X; Schafer PH; Chen Y; Garcia BM; Lee TY
Radiology; 2012 Jul; 264(1):68-77. PubMed ID: 22627603
[TBL] [Abstract][Full Text] [Related]
38. Early changes in liver perfusion caused by occult metastases in rats: detection with quantitative CT.
Cuenod C; Leconte I; Siauve N; Resten A; Dromain C; Poulet B; Frouin F; Clément O; Frija G
Radiology; 2001 Feb; 218(2):556-61. PubMed ID: 11161178
[TBL] [Abstract][Full Text] [Related]
39. Regional blood flow, capillary permeability, and compartmental volumes: measurement with dynamic CT--initial experience.
Brix G; Bahner ML; Hoffmann U; Horvath A; Schreiber W
Radiology; 1999 Jan; 210(1):269-76. PubMed ID: 9885619
[TBL] [Abstract][Full Text] [Related]
40. Open four-compartment model in the measurement of liver perfusion.
Kapanen MK; Halavaara JT; Häkkinen AM
Acad Radiol; 2005 Dec; 12(12):1542-50. PubMed ID: 16321743
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
